Published in Prog Neurobiol on October 16, 2010
Interneuron dysfunction in psychiatric disorders. Nat Rev Neurosci (2012) 2.87
Paternal stress exposure alters sperm microRNA content and reprograms offspring HPA stress axis regulation. J Neurosci (2013) 2.52
Schizophrenia. Lancet (2016) 1.83
Schizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation? Pediatr Res (2011) 1.62
Animal models of schizophrenia. Br J Pharmacol (2011) 1.60
Susceptibility to a parkinsonian toxin varies during primate development. Exp Neurol (2012) 1.41
The dynamics of DNA methylation in schizophrenia and related psychiatric disorders. Neuropsychopharmacology (2012) 1.40
The dappled nature of causes of psychiatric illness: replacing the organic-functional/hardware-software dichotomy with empirically based pluralism. Mol Psychiatry (2012) 1.35
Social deprivation, inequality, and the neighborhood-level incidence of psychotic syndromes in East London. Schizophr Bull (2012) 1.17
Gene-environment interactions in severe mental illness. Front Psychiatry (2014) 1.09
Mechanisms of lead and manganese neurotoxicity. Toxicol Res (Camb) (2013) 1.09
Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A "central hub" in schizophrenia pathophysiology? Schizophr Res (2014) 1.06
Modeling heterogeneous patients with a clinical diagnosis of schizophrenia with induced pluripotent stem cells. Biol Psychiatry (2013) 1.05
Immune system gene dysregulation in autism and schizophrenia. Dev Neurobiol (2012) 1.04
Reduced ventricular proliferation in the foetal cortex following maternal inflammation in the mouse. Brain (2011) 1.03
Social isolation exacerbates schizophrenia-like phenotypes via oxidative stress in cortical interneurons. Biol Psychiatry (2013) 1.02
Inflammatory molecular signature associated with infectious agents in psychosis. Schizophr Bull (2014) 1.02
Gastrointestinal inflammation and associated immune activation in schizophrenia. Schizophr Res (2012) 1.01
Schizophrenia: do all roads lead to dopamine or is this where they start? Evidence from two epidemiologically informed developmental rodent models. Transl Psychiatry (2012) 1.00
Major histocompatibility complex I in brain development and schizophrenia. Biol Psychiatry (2013) 0.99
Immune system disturbances in schizophrenia. Biol Psychiatry (2013) 0.99
Schizophrenia: a tale of two critical periods for prefrontal cortical development. Transl Psychiatry (2015) 0.99
The consequences of chorioamnionitis: preterm birth and effects on development. J Pregnancy (2013) 0.99
Translational epidemiology in psychiatry: linking population to clinical and basic sciences. Arch Gen Psychiatry (2011) 0.98
Inflammation and the two-hit hypothesis of schizophrenia. Neurosci Biobehav Rev (2013) 0.98
The role of schizotypy in the study of the etiology of schizophrenia spectrum disorders. Schizophr Bull (2015) 0.98
Transcriptome study of differential expression in schizophrenia. Hum Mol Genet (2013) 0.97
Latent toxoplasmosis and human. Iran J Parasitol (2012) 0.97
Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap. Nat Rev Drug Discov (2012) 0.97
Neurodevelopment, GABA system dysfunction, and schizophrenia. Neuropsychopharmacology (2014) 0.96
Viral infection, inflammation and schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.96
Targeting Oxidative Stress and Aberrant Critical Period Plasticity in the Developmental Trajectory to Schizophrenia. Schizophr Bull (2015) 0.95
Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis. Nat Rev Neurosci (2016) 0.94
Peptide sharing between influenza A H1N1 hemagglutinin and human axon guidance proteins. Schizophr Bull (2013) 0.93
Oxytocin in schizophrenia: a review of evidence for its therapeutic effects. Acta Neuropsychiatr (2011) 0.93
Identification of subgroups of schizophrenia patients with changes in either immune or growth factor and hormonal pathways. Schizophr Bull (2013) 0.92
Complement C1q formation of immune complexes with milk caseins and wheat glutens in schizophrenia. Neurobiol Dis (2012) 0.92
Mismatch negativity encoding of prediction errors predicts S-ketamine-induced cognitive impairments. Neuropsychopharmacology (2011) 0.91
Differential effects of environmental enrichment, social-housing, and isolation-rearing on a rat gambling task: dissociations between impulsive action and risky decision-making. Psychopharmacology (Berl) (2012) 0.91
Environmental Risk and Protective Factors and Their Influence on the Emergence of Psychosis. Adolesc Psychiatry (Hilversum) (2012) 0.91
Microglial activation and progressive brain changes in schizophrenia. Br J Pharmacol (2016) 0.90
Perineuronal nets and schizophrenia: the importance of neuronal coatings. Neurosci Biobehav Rev (2014) 0.90
Convergence of genetic and environmental factors on parvalbumin-positive interneurons in schizophrenia. Front Behav Neurosci (2013) 0.89
DISC1 mouse models as a tool to decipher gene-environment interactions in psychiatric disorders. Front Behav Neurosci (2013) 0.88
Prenatal activation of Toll-like receptors-3 by administration of the viral mimetic poly(I:C) changes synaptic proteins, N-methyl-D-aspartate receptors and neurogenesis markers in offspring. Mol Brain (2012) 0.88
DISC1 variants 37W and 607F disrupt its nuclear targeting and regulatory role in ATF4-mediated transcription. Hum Mol Genet (2012) 0.88
Genetics of bipolar disorder. Appl Clin Genet (2014) 0.87
Cognitive interventions targeting brain plasticity in the prodromal and early phases of schizophrenia. Annu Rev Clin Psychol (2013) 0.86
Is lead exposure in early life an environmental risk factor for Schizophrenia? Neurobiological connections and testable hypotheses. Neurotoxicology (2011) 0.86
Obstetric complications as risk factors for schizophrenia spectrum psychoses in offspring of mothers with psychotic disorder. Schizophr Bull (2012) 0.86
Obstetric and neonatal outcomes after antipsychotic medication exposure in pregnancy. Obstet Gynecol (2015) 0.86
Toxoplasmosis and Polygenic Disease Susceptibility Genes: Extensive Toxoplasma gondii Host/Pathogen Interactome Enrichment in Nine Psychiatric or Neurological Disorders. J Pathog (2013) 0.85
Schizophrenia as a disorder of molecular pathways. Biol Psychiatry (2014) 0.85
Dendritic spine alterations in schizophrenia. Neurosci Lett (2014) 0.84
Comparison of children with autism spectrum disorder with and without schizophrenia spectrum traits: gender, season of birth, and mental health risk factors. J Autism Dev Disord (2012) 0.83
Relationship between Interleukin-6 gene polymorphism and hippocampal volume in antipsychotic-naïve schizophrenia: evidence for differential susceptibility? PLoS One (2014) 0.83
Chronic exposure of mutant DISC1 mice to lead produces sex-dependent abnormalities consistent with schizophrenia and related mental disorders: a gene-environment interaction study. Schizophr Bull (2013) 0.83
The Kraepelinian Dichotomy From the Perspective of Prenatal Infectious and Immunologic Insults. Schizophr Bull (2015) 0.82
Molecular substrates of schizophrenia: homeostatic signaling to connectivity. Mol Psychiatry (2015) 0.82
A heme oxygenase-1 transducer model of degenerative and developmental brain disorders. Int J Mol Sci (2015) 0.81
Low maternal retinol as a risk factor for schizophrenia in adult offspring. Schizophr Res (2012) 0.81
Raising attention to attention deficit hyperactivity disorder in schizophrenia. World J Psychiatry (2015) 0.80
Epigenetics and nutritional environmental signals. Integr Comp Biol (2014) 0.80
New insights into behaviour using mouse ENU mutagenesis. Hum Mol Genet (2012) 0.80
Htr2a Expression Responds Rapidly to Environmental Stimuli in an Egr3-Dependent Manner. ACS Chem Neurosci (2015) 0.80
The expression of nicotinic receptor alpha7 during cochlear development. Brain Behav (2012) 0.80
Developmental vitamin D deficiency and schizophrenia: the role of animal models. Genes Brain Behav (2016) 0.80
Influence of antipsychotic drugs on human endogenous retrovirus (HERV) transcription in brain cells. PLoS One (2012) 0.80
Advanced paternal age increases the risk of schizophrenia and obsessive-compulsive disorder in a Chinese Han population. Psychiatry Res (2012) 0.80
Hypothyroxinemia During Gestation and Offspring Schizophrenia in a National Birth Cohort. Biol Psychiatry (2015) 0.79
Potential primary roles of glial cells in the mechanisms of psychiatric disorders. Front Cell Neurosci (2015) 0.79
Animal models of gene-environment interaction in schizophrenia: A dimensional perspective. Prog Neurobiol (2015) 0.79
Early-life lead exposure recapitulates the selective loss of parvalbumin-positive GABAergic interneurons and subcortical dopamine system hyperactivity present in schizophrenia. Transl Psychiatry (2015) 0.79
Cholecystokinin A receptor (CCKAR) gene variation is associated with language lateralization. PLoS One (2013) 0.79
Induced pluripotent stem cells for modeling neurological disorders. World J Transplant (2015) 0.79
DNA Damage and Repair in Schizophrenia and Autism: Implications for Cancer Comorbidity and Beyond. Int J Mol Sci (2016) 0.79
Maternal-fetal blood incompatibility and neuromorphologic anomalies in schizophrenia: Preliminary findings. Prog Neuropsychopharmacol Biol Psychiatry (2011) 0.79
Prenatal nutritional deficiency reprogrammed postnatal gene expression in mammal brains: implications for schizophrenia. Int J Neuropsychopharmacol (2014) 0.79
Inflammation and the neural diathesis-stress hypothesis of schizophrenia: a reconceptualization. Transl Psychiatry (2017) 0.78
Impact of early adverse experience on complexity of adult-generated neurons. Transl Psychiatry (2011) 0.78
Validating reference genes using minimally transformed qpcr data: findings in human cortex and outcomes in schizophrenia. BMC Psychiatry (2016) 0.78
Modeling the molecular epigenetic profile of psychosis in prenatally stressed mice. Prog Mol Biol Transl Sci (2014) 0.78
Motor stereotypies and cognitive perseveration in non-human primates exposed to early gestational irradiation. Neuroscience (2013) 0.78
Prenatal inhibition of the kynurenine pathway leads to structural changes in the hippocampus of adult rat offspring. Eur J Neurosci (2014) 0.78
Cannabidiol as a Potential New Type of an Antipsychotic. A Critical Review of the Evidence. Front Pharmacol (2016) 0.78
Chronic Toxoplasma gondii in Nurr1-null heterozygous mice exacerbates elevated open field activity. PLoS One (2015) 0.77
Disease signatures for schizophrenia and bipolar disorder using patient-derived induced pluripotent stem cells. Mol Cell Neurosci (2016) 0.77
Schizophrenia in the spectrum of gene-stress interactions: the FKBP5 example. Schizophr Bull (2015) 0.77
Therapeutic Targets for Neurodevelopmental Disorders Emerging from Animal Models with Perinatal Immune Activation. Int J Mol Sci (2015) 0.77
Electrophysiological endophenotypes in rodent models of schizophrenia and psychosis. Biol Psychiatry (2015) 0.77
Meta-analysis of sex differences in gene expression in schizophrenia. BMC Syst Biol (2016) 0.77
Administration of Non-Absorbable Antibiotics to Pregnant Mice to Perturb the Maternal Gut Microbiota Is Associated with Alterations in Offspring Behavior. PLoS One (2016) 0.77
Altered hippocampal plasticity by prenatal kynurenine administration, kynurenine-3-monoxygenase (KMO) deletion or galantamine. Neuroscience (2015) 0.77
The emerging molecular architecture of schizophrenia, polygenic risk scores and the clinical implications for gXe research. Soc Psychiatry Psychiatr Epidemiol (2014) 0.76
A conceptual and practical guide to the behavioural evaluation of animal models of the symptomatology and therapy of schizophrenia. Cell Tissue Res (2013) 0.76
Impact of Adverse Childhood Experiences on Psychotic-Like Symptoms and Stress Reactivity in Daily Life in Nonclinical Young Adults. PLoS One (2016) 0.76
Common variants of the PINK1 and PARL genes do not confer genetic susceptibility to schizophrenia in Han Chinese. Mol Genet Genomics (2014) 0.76
Converging models of schizophrenia - Network alterations of prefrontal cortex underlying cognitive impairments. Prog Neurobiol (2015) 0.76
Sex differences in GABAergic gene expression occur in the anterior cingulate cortex in schizophrenia. Schizophr Res (2015) 0.76
Isochromosome 13 in a patient with childhood-onset schizophrenia, ADHD, and motor tic disorder. Mol Cytogenet (2012) 0.75
Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature (2009) 33.26
Maternal and child undernutrition: global and regional exposures and health consequences. Lancet (2008) 26.44
CpG-rich islands and the function of DNA methylation. Nature (1986) 24.90
Apoptosis in the pathogenesis and treatment of disease. Science (1995) 20.24
Heritability in the genomics era--concepts and misconceptions. Nat Rev Genet (2008) 13.42
Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci (2005) 11.68
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet (2007) 11.27
Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry (2003) 10.44
Common variants conferring risk of schizophrenia. Nature (2009) 10.37
Regional differences in synaptogenesis in human cerebral cortex. J Comp Neurol (1997) 9.09
Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry (1987) 8.81
Cohort profile: the Norwegian Mother and Child Cohort Study (MoBa). Int J Epidemiol (2006) 8.45
Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature (2009) 8.12
Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr (2002) 7.34
Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study. Psychol Med Monogr Suppl (1992) 7.04
A systematic review of the prevalence of schizophrenia. PLoS Med (2005) 6.99
Synaptic density in human frontal cortex - developmental changes and effects of aging. Brain Res (1979) 6.68
Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci U S A (2001) 6.68
The origins, patterns and implications of human spontaneous mutation. Nat Rev Genet (2000) 6.44
The Danish National Birth Cohort--its background, structure and aim. Scand J Public Health (2001) 6.09
Effects of family history and place and season of birth on the risk of schizophrenia. N Engl J Med (1999) 5.48
Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am J Psychiatry (2010) 5.27
Socioeconomic status and psychiatric disorders: the causation-selection issue. Science (1992) 4.95
Schizophrenia following pre-natal exposure to influenza epidemics between 1939 and 1960. Br J Psychiatry (1992) 4.94
Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol Psychiatry (2005) 4.85
Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatry (2000) 4.84
Schizophrenia and migration: a meta-analysis and review. Am J Psychiatry (2005) 4.59
Support for the involvement of large copy number variants in the pathogenesis of schizophrenia. Hum Mol Genet (2009) 4.52
Brain abnormality in schizophrenia. A systematic and quantitative review of volumetric magnetic resonance imaging studies. Br J Psychiatry (1998) 4.42
Schizophrenia as a disorder of neurodevelopment. Annu Rev Neurosci (2002) 4.36
Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? J Psychiatr Res (1984) 4.28
Child development risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet (1994) 4.28
White matter changes in schizophrenia: evidence for myelin-related dysfunction. Arch Gen Psychiatry (2003) 4.25
Maternal immune activation alters fetal brain development through interleukin-6. J Neurosci (2007) 4.06
Obstetric complications and schizophrenia: historical and meta-analytic review. Am J Psychiatry (2002) 4.03
Epigenetic epidemiology of the developmental origins hypothesis. Annu Rev Nutr (2007) 3.91
Rates of adult schizophrenia following prenatal exposure to the Chinese famine of 1959-1961. JAMA (2005) 3.83
Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch Gen Psychiatry (2010) 3.82
Schizophrenia after prenatal famine. Further evidence. Arch Gen Psychiatry (1996) 3.65
Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet (1987) 3.61
Advancing paternal age and autism. Arch Gen Psychiatry (2006) 3.58
Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiatry (2004) 3.52
Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J Neurosci (2003) 3.50
Advancing paternal age and the risk of schizophrenia. Arch Gen Psychiatry (2001) 3.48
Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia. Proc Natl Acad Sci U S A (2001) 3.45
A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Med (2004) 3.40
Impact of child sexual abuse on mental health: prospective study in males and females. Br J Psychiatry (2004) 3.39
Childhood antecedents of schizophrenia and affective illness: social adjustment at ages 7 and 11. BMJ (1994) 3.33
Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci U S A (1996) 3.28
The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am J Psychiatry (2001) 3.20
Immune involvement in schizophrenia and autism: etiology, pathology and animal models. Behav Brain Res (2008) 3.12
Schizophrenia after prenatal exposure to the Dutch Hunger Winter of 1944-1945. Arch Gen Psychiatry (1992) 3.10
Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ (2002) 3.06
The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J Neurosci (2006) 3.03
Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study. Arch Gen Psychiatry (1998) 2.92
Childhood abuse as a risk factor for psychotic experiences. Acta Psychiatr Scand (2004) 2.86
Cannabis use and psychosis: a longitudinal population-based study. Am J Epidemiol (2002) 2.80
Epigenetics and human disease. Annu Rev Genomics Hum Genet (2004) 2.78
Placental corticotropin-releasing hormone (CRH), spontaneous preterm birth, and fetal growth restriction: a prospective investigation. Am J Obstet Gynecol (2004) 2.75
Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. BMJ (2002) 2.74
Glucocorticoids, prenatal stress and the programming of disease. Horm Behav (2010) 2.72
Immune proteins in brain development and synaptic plasticity. Neuron (2009) 2.72
Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr Res (1997) 2.70
Higher risk of offspring schizophrenia following antenatal maternal exposure to severe adverse life events. Arch Gen Psychiatry (2008) 2.69
Race and risk of schizophrenia in a US birth cohort: another example of health disparity? Int J Epidemiol (2007) 2.67
Normal development of brain circuits. Neuropsychopharmacology (2010) 2.64
Adult schizophrenia following prenatal exposure to an influenza epidemic. Arch Gen Psychiatry (1988) 2.62
Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring. Am J Psychiatry (2005) 2.60
Imprinting and the epigenetic asymmetry between parental genomes. Science (2001) 2.56
Evidence of a dose-response relationship between urbanicity during upbringing and schizophrenia risk. Arch Gen Psychiatry (2001) 2.49
IQ and risk for schizophrenia: a population-based cohort study. Psychol Med (1997) 2.47
Ethnic density of neighborhoods and incidence of psychotic disorders among immigrants. Am J Psychiatry (2007) 2.45
Relationship of iron to oligodendrocytes and myelination. Glia (1996) 2.44
Sex differences in the risk of schizophrenia: evidence from meta-analysis. Arch Gen Psychiatry (2003) 2.41
Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders. Brain Res Rev (2006) 2.36
Paternal age and risk for schizophrenia. Br J Psychiatry (2003) 2.34
Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report. Am J Med Genet B Neuropsychiatr Genet (2005) 2.34
Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis. Schizophr Bull (2006) 2.34
Maternal infections and subsequent psychosis among offspring. Arch Gen Psychiatry (2001) 2.33
Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia. Nat Neurosci (2002) 2.32
Models for the joint effect of genotype and environment on liability to psychiatric illness. Am J Psychiatry (1986) 2.29
Paternal age and schizophrenia: a population based cohort study. BMJ (2004) 2.27
Prenatal exposure to maternal stress and subsequent schizophrenia. The May 1940 invasion of The Netherlands. Br J Psychiatry (1998) 2.24
Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring. Am J Psychiatry (2004) 2.23
Incidence of schizophrenia in ethnic minorities in London: ecological study into interactions with environment. BMJ (2001) 2.22
Impact of complex genetic variation in COMT on human brain function. Mol Psychiatry (2006) 2.22
Evidence for an interaction between familial liability and prenatal exposure to infection in the causation of schizophrenia. Am J Psychiatry (2009) 2.21
Myelination of cortical-hippocampal relays during late adolescence. Schizophr Bull (1989) 2.19
Environment and schizophrenia: environmental factors in schizophrenia: childhood trauma--a critical review. Schizophr Bull (2006) 2.19
Epigenetics and the environmental regulation of the genome and its function. Annu Rev Psychol (2010) 2.16
Cytokines and CNS development. Neuron (2009) 2.15
Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia. Biol Psychiatry (2007) 2.12
Discrimination and the incidence of psychotic disorders among ethnic minorities in The Netherlands. Int J Epidemiol (2007) 2.12
DNA damage from micronutrient deficiencies is likely to be a major cause of cancer. Mutat Res (2001) 2.09
Redox dysregulation, neurodevelopment, and schizophrenia. Curr Opin Neurobiol (2009) 2.09
Contributions of genetic risk and fetal hypoxia to hippocampal volume in patients with schizophrenia or schizoaffective disorder, their unaffected siblings, and healthy unrelated volunteers. Am J Psychiatry (2002) 2.08
Loss of imprinting of insulin growth factor II gene: a potential heritable biomarker for colon neoplasia predisposition. Gastroenterology (2004) 2.06
Seasonality of births in schizophrenia and bipolar disorder: a review of the literature. Schizophr Res (1997) 2.06
Vitamin D3 and brain development. Neuroscience (2003) 2.01
DNA methyltransferase inhibitors coordinately induce expression of the human reelin and glutamic acid decarboxylase 67 genes. Mol Pharmacol (2006) 1.95